1. AHRO : Austin Health Research Online

Elif I Ekinci

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Elif I Ekinci
Full Name
Ekinci, Elif I
 
elif photo[1].png picture
Department
 
LinkedIn
ORCID
Twitter
Biography
A/Prof Elif Ekinci is a clinician researcher, an academic endocrinologist who is working to translate research into improved outcomes for people with type 1 and type 2 diabetes. Head of Diabetes at Austin Health, and Director of the Australian Centre for Accelerating Diabetes Innovations (ACADI).
 
Loading... 3 0 20 0 false

Publications

Results 21-40 of 156 (Search time: 0.007 seconds).

Publication YearTitleAuthor(s)
21Jun-2022Feasibility study of a prototype extended-wear insulin infusion set in adults with type 1 diabetes.Kastner, Jasmin R; Venkatesh, Nisha; Brown, Katie; Muchmore, Douglas B; Ekinci, Elif I ; Fourlanos, Spiros; Joseph, Jeffrey I; Shafeeq, Miami; Shi, Leon; Strange, Poul; Strasma, Paul J; O'Neal, David N
2217-May-2022Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring.Yapanis, Michael; James, Steven; Craig, Maria E; O'Neal, David; Ekinci, Elif I 
2328-Feb-2022Blood Plasma Metabolites in Diabetes-Associated Chronic Kidney Disease: A Focus on Lipid Profiles and Cardiovascular Risk.Lecamwasam, Ashani ; Mansell, Toby; Ekinci, Elif I ; Saffery, Richard; Dwyer, Karen M
24Feb-2022Role of the adaptive immune system in diabetic kidney disease.Kong, Lingyun; Andrikopoulos, Sofianos; MacIsaac, Richard J; Mackay, Laura K; Nikolic-Paterson, David J; Torkamani, Niloufar ; Zafari, Neda; Marin, Evelyn C S; Ekinci, Elif I 
251-Jan-2022Response to Comment on Hamblin et al. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes. Diabetes Care 2021;44:e124-e126.Hamblin, Peter S; Wong, Rosemary; Ekinci, Elif I ; Sztal-Mazer, Shoshana; Balachandran, Shananthan; Frydman, Aviva S ; Hanrahan, Timothy P; Hu, Raymond T C ; Ket, Shara N; Moss, Alan; Ng, Mark; Ragunathan, Sashikala; Bach, Leon A
262022Efficacy of Flash Glucose Monitoring in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.Liang, Bonnie; Koye, Digsu N; Hachem, Mariam; Zafari, Neda; Braat, Sabine; Ekinci, Elif I 
272022Novel Therapies for Kidney Disease in People with Diabetes.Khurana, Nayana; James, Steven; Coughlan, Melinda T; MacIsaac, Richard J; Ekinci, Elif I 
282022Functional MRI in assessment of diabetic kidney disease in people with type 1 diabetes.Seah, Jas-Mine ; Botterill, Elissa; MacIsaac, Richard J; Milne, Michele; Ekinci, Elif I ; Lim, Ruth P 
292022Body mass index is inversely associated with capillary ketones at the time of colonoscopy: Implications for SGLT2i use.Hamblin, Peter S; Wong, Rosemary; Ekinci, Elif I ; Sztal-Mazer, Shoshana; Balachandran, Shananthan; Frydman, Aviva S ; Hanrahan, Timothy P; Hu, Raymond T C ; Ket, Shara N; Moss, Alan; Ng, Mark; Ragunathan, Sashikala; Bach, Leon A
302022The ambulatory glucose profile and its interpretation.Lin, Rose; Brown, Fran; Ekinci, Elif I 
31Dec-2021The comparative epidemiology and outcomes of hospitalized patients treated with SGLT2 or DPP4 inhibitors.Huang, Warren ; Whitelaw, Jack; Kishore, Kartik ; Neto, Ary Serpa; Holmes, Natasha E ; Marhoon, Nada ; Bellomo, Rinaldo ; Ekinci, Elif I 
3230-Nov-2021The role of the adaptive immune system in diabetic kidney disease (DKD).Kong, Lingyun; Andrikopoulos, Sofianos; MacIsaac, Richard; Mackay, Laura K; Nikolic-Paterson, David J; Torkamani, Niloufar ; Zafari, Neda; Marin, Evelyn C S; Ekinci, Elif I 
33Oct-2021Older People With Type 2 Diabetes-Individualising Management With a Specialised Community Team (OPTIMISE): Perspectives of Participants on Care.Ogrin, Rajna; Aylen, Tracy; Thurgood, Lorenna; Neoh, Sandra L ; Audehm, Ralph; Steel, Paul; Churilov, Leonid ; Zajac, Jeffrey D ; Ekinci, Elif I 
34Oct-2021Comparison of two questionnaires for assessment of emotional eating in people undergoing treatment for obesity.Stammers, Lauren; Wong, Lisa; Churilov, Leonid ; Price, Sarah A ; Ekinci, Elif I ; Sumithran, Priya 
35Sep-2021Feasibility of once weekly exenatide-LAR and enhanced diabetes care in Indigenous Australians with type 2 diabetes (Long-acting-Once-Weekly-Exenatide laR-SUGAR, 'Lower SUGAR' study).Ekinci, Elif I ; Pyrlis, Felicity ; Hachem, Mariam; Maple-Brown, Louise J; Brown, Alex; Maguire, Graeme; Churilov, Leonid ; Cohen, Neale
3625-Aug-2021Sodium glucose co-transporter-2 inhibitor-induced diabetic ketoacidosis following tooth extraction: Improving awareness among dental practitioners.Yap, Sin Dee; Hamblin, Peter Shane; Bach, Leon; Ekinci, Elif I ; Wong, Rosemary
37Aug-2021Reply - Letter to the editor.Churilov, Irina; Churilov, Leonid ; Brock, Kim; Murphy, David; MacIsaac, Richard J; Ekinci, Elif I 
38May-2021Gut microbiome, prebiotics, intestinal permeability and diabetes complications.Snelson, Matthew; de Pasquale, Cassandra; Ekinci, Elif I ; Coughlan, Melinda T
3925-Apr-2021Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes.Hamblin, Peter S; Wong, Rosemary; Ekinci, Elif I ; Sztal-Mazer, Shoshana; Balachandran, Shananthan; Frydman, Aviva ; Hanrahan, Timothy P; Hu, Raymond T C ; Ket, Shara N; Moss, Alan; Ng, Mark; Ragunathan, Sashikala; Bach, Leon A
40Apr-2021Feasibility trial of metformin XR in people with pre-diabetes and stroke (MIPPS)-randomised open blinded endpoint controlled trial.Tabesh, Marjan; Hachem, Mariam; Lau, Lik-Hui; Borschmann, Karen ; Churilov, Leonid ; Price, Sarah A L; Sumithran, Priya ; Donnan, Geoffrey A ; Zajac, Jeffrey D ; Thijs, Vincent N ; Ekinci, Elif I